Almac Sciences has this year announced details of its “First in Man” approach to peptide synthesis. This embraces and offers development of peptide synthesis, full analytical support (including method ...

Almac has created a new non-GMP formulation development facility and two new analytical laboratories at their U.K. headquarters in Craigavon to expand its drug product pharmaceutical development ...

Craigavon, N.I., UK, - 09 November 2015 - Almac Group, the global contract development and manufacturing organisation, has confirmed a £16 million investment to expand its formulation and analytical ...

To win at the drug development game, it’s not enough to show up with a great molecule. Many compounds would stall at the discovery stage without effective ways to get them inside patients. But the ...

Following the success of one of its key client partnered products, Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Together with the recent ...

This investment is additional to and separate from £11 million that was announced in the fall of 2024 for creating new jobs and expanding Almac’s global analytical services capabilities. Almac ...

Almac Group has completed a multi-million-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK. The significant investment by Almac Pharma Services, will ...

> Almac has doubled its drug product development capacity with a new non-GMP formulation facility and two analytical laboratories at its U.K. headquarters. News ...

Almac and VTU Technology have announced their collaboration to offer joint services for the expression of recombinant proteins with site-specific modification and labelling, such as PEGylation for ...

When AstraZeneca ($AZN) abandoned its campus in Charnwood in the U.K. some years back, it left new owners to figure out what would be done with the facilities. Now ...

Almac Sciences, a member of the Almac Group, said today it has expanded its suite of analytical solutions to include biologics testing solutions. The company said its services will now include, in ...

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Almac Discovery, a ...